BlackRock, Inc. (BLK) 13D/13G Filings for OncoCyte Corporation (OCX)

BlackRock, Inc. 13D and 13G filings for OncoCyte Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-05-09
3:23 pm
Purchase		 2022-04-30 13G OncoCyte Corporation
OCX		 BlackRock Inc.
BLK		 250,261
4.200%		 604increase
(+0.24%)		 Filing
2022-02-04
4:12 pm
Purchase		 2021-12-31 13G OncoCyte Corporation
OCX		 BlackRock Inc.
BLK		 249,657
5.400%		 69,906increase
(+38.89%)		 Filing
2021-02-10
3:04 pm
Purchase		 2021-01-31 13G OncoCyte Corporation
OCX		 BlackRock Inc.
BLK		 179,752
4.600%		 4,650increase
(+2.66%)		 Filing
2021-02-02
3:13 pm
Purchase		 2020-12-31 13G OncoCyte Corporation
OCX		 BlackRock Inc.
BLK		 175,102
5.200%		 175,102increase
(New Position)		 Filing